Real-World Impact of COVID-19 on Subcutaneous Immunotherapy Persistence and Efficacy in Allergic Rhinitis

Xuan Yuan; Liyuan Liu; Benjian Zhang; Shaobing Xie; Lai Meng; Wei Zhong; Jiaxin Jia; Hua Zhang; Weihong Jiang; Zhihai Xie

doi:10.1111/all.16467

Real-World Impact of COVID-19 on Subcutaneous Immunotherapy Persistence and Efficacy in Allergic Rhinitis

Allergy. 2025 Jan 5. doi: 10.1111/all.16467. Online ahead of print.

Authors

Xuan Yuan^{1

2

3

4}, Liyuan Liu⁵, Benjian Zhang^{1

2

3

4}, Shaobing Xie^{1

2

3

4}, Lai Meng^{1

2

3

4}, Wei Zhong^{1

2

3

4}, Jiaxin Jia^{1

2

3

4}, Hua Zhang^{1

2

3

4}, Weihong Jiang^{1

2

3

4}, Zhihai Xie^{1

2

3

4}

Affiliations

¹ Department of Otolaryngology Head and Neck Surgery, Xiangya Hospital of Central South University, Changsha, China.
² Hunan Province Key Laboratory of Otolaryngology Critical Diseases, Xiangya Hospital of Central South University, Changsha, China.
³ National Clinical Research Center for Geriatric Disorders, Xiangya Hospital of Central South University, Changsha, China.
⁴ Anatomy Laboratory of Division of Nose and Cranial Base, Clinical Anatomy Center of Xiangya Hospital, Central South University, Changsha, China.
⁵ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

PMID: 39757758
DOI: 10.1111/all.16467

No abstract available

Publication types

Letter

Publication types

Grants and funding